Miyamoto Yoko, Taniguchi Hiroaki, Hamel Frédéric, Silversides David W, Viger Robert S
Ontogeny-Reproduction Research Unit, Centre de Recherche du Centre Hospitalier Universitaire de Quebec (CRCHUQ), Quebec City, QC, G1V 4G2, Canada.
BMC Mol Biol. 2008 Apr 29;9:44. doi: 10.1186/1471-2199-9-44.
In mammals, sex determination is genetically controlled. The SRY gene, located on Y chromosome, functions as the dominant genetic switch for testis development. The SRY gene is specifically expressed in a subpopulation of somatic cells (pre-Sertoli cells) of the developing urogenital ridge for a brief period during gonadal differentiation. Despite this tight spatiotemporal expression pattern, the molecular mechanisms that regulate SRY transcription remain poorly understood. Sry expression has been shown to be markedly reduced in transgenic mice harboring a mutant GATA4 protein (a member of the GATA family of transcription factors) disrupted in its ability to interact with its transcriptional partner FOG2, suggesting that GATA4 is involved in SRY gene transcription.
Although our results show that GATA4 directly targets the pig SRY promoter, we did not observe similar action on the mouse and human SRY promoters. In the mouse, Wilms' tumor 1 (WT1) is an important regulator of both Sry and Müllerian inhibiting substance (Amh/Mis) expression and in humans, WT1 mutations are associated with abnormalities of sex differentiation. GATA4 transcriptionally cooperated with WT1 on the mouse, pig, and human SRY promoters. Maximal GATA4/WT1 synergism was dependent on WT1 but not GATA4 binding to their consensus regulatory elements in the SRY promoter and required both the zinc finger and C-terminal regions of the GATA4 protein. Although both isoforms of WT1 synergized with GATA4, synergism was stronger with the +KTS rather than the -KTS isoform. WT1/GATA4 synergism was also observed on the AMH promoter. In contrast to SRY, WT1/GATA4 action on the mouse Amh promoter was specific for the -KTS isoform and required both WT1 and GATA4 binding.
Our data therefore provide new insights into the molecular mechanisms that contribute to the tissue-specific expression of the SRY and AMH genes in both normal development and certain syndromes of abnormal sex differentiation.
在哺乳动物中,性别决定受基因控制。位于Y染色体上的SRY基因,作为睾丸发育的主要遗传开关发挥作用。SRY基因在性腺分化期间的短时间内,在发育中的泌尿生殖嵴的体细胞亚群(前支持细胞)中特异性表达。尽管存在这种严格的时空表达模式,但调节SRY转录的分子机制仍知之甚少。在携带突变型GATA4蛋白(转录因子GATA家族成员)且其与转录伴侣FOG2相互作用能力受损的转基因小鼠中,Sry表达已被证明显著降低,这表明GATA4参与SRY基因转录。
虽然我们的结果表明GATA4直接靶向猪的SRY启动子,但我们未在小鼠和人类SRY启动子上观察到类似作用。在小鼠中,威尔姆斯瘤1(WT1)是Sry和苗勒管抑制物质(Amh/Mis)表达的重要调节因子,在人类中,WT1突变与性别分化异常有关。GATA4在小鼠、猪和人类SRY启动子上与WT1进行转录协同作用。最大的GATA4/WT1协同作用依赖于WT1,但不依赖于GATA4与SRY启动子中其共有调控元件的结合,并且需要GATA4蛋白的锌指和C末端区域。虽然WT1的两种异构体都与GATA4协同作用,但与+KTS异构体的协同作用比-KTS异构体更强。在AMH启动子上也观察到WT1/GATA4协同作用。与SRY不同,WT1/GATA4对小鼠Amh启动子的作用对-KTS异构体具有特异性,并且需要WT1和GATA4的结合。
因此,我们的数据为正常发育和某些异常性别分化综合征中SRY和AMH基因组织特异性表达的分子机制提供了新的见解。